Results 21 to 30 of about 2,402,251 (269)
A Speciation Study on the Perturbing Effects of Iron Chelators on the Homeostasis of Essential Metal Ions. [PDF]
PLoS ONE, 2015 A number of reports have appeared in literature calling attention to the depletion of essential metal ions during chelation therapy on β-thalassaemia patients.
Guido Crisponi +6 more
doaj +1 more source
Chelation therapy after the Trial to Assess Chelation Therapy [PDF]
Current Opinion in Cardiology, 2014 EDTA chelation therapy has been in off-label use for the treatment of atherosclerosis. We review the results of the first large-scale randomized trial of this treatment.The trial to assess chelation therapy was a $30 million National Institutes of Health-funded study of the safety and efficacy of EDTA-based chelation infusions in 1708 post-myocardial ...
Avila, Maria D. +2 more
openaire +2 more sources
Медицинский совет, 2016 Iron overload (RV) is a condition caused by excessive intake of iron, and in the absence of the specific mechanisms for its excretion - excessive accumulation in tissues and their subsequent lesion leading to functional organ failure [1].
M. V. Krasolnikova
doaj +1 more source
Assessment of Thalassemic Children Knowledge about Thalassemia and Iron Chelation Therapy [PDF]
Port Said Scientific Journal of Nursing, 2019 Background: Thalassemia is a major inherited public health problem in the Mediterranean area. Aim of this study was to assess children knowledge about thalassemia and iron chelation therapy. Subjects and methods: A descriptive research design was used. A
Rehab Hanie El-Kazaz +3 more
doaj +1 more source
Overview of chelation recommendations for thalassaemia and sickle cell disease
Thalassemia Reports, 2014 The long term consequences of iron toxicity are mostly reversible with effective iron chelation therapy. Recommendations for use of chelation therapy in transfusion dependent thalassaemia (TDT), sickle cell disease (SCD) and non transfusion dependent ...
Banu Kaya
doaj +1 more source
Journal of Applied Hematology, 2023 BACKGROUND: Thalassemia is severe public health problem in Iraq and other nearby countries, represents about 75% of all hemogloniopathy with prevalence and incidence 36/100.000 and 34/100.000 respectively.
Mohammed Ali Al-Jabory +2 more
doaj +1 more source
Iron Chelation Therapy in COVID-19 Infection
Southeastern European Medical Journal, 2022 The recent outbreak of corona virus and coronavirus disease (COVID-19) caused by the SARS-CoV-2 virus is a global concern. Despite efforts to clarify the physiology and potential therapy, specific guidelines for the treatment of COVID-19 disease have yet
Irena Krajina Kmoniček +2 more
doaj +1 more source
Importance of iron chelation therapy
Thalassemia Reports, 2011 It is necessary to remember that today patients have different options of chelation treatment, as desferrioxamine, deferiprone and deferasirox are available. However, a patient has to be compliant with treatments.
A. Varoğlu
doaj +1 more source
Effect of Chelation Therapy on a Korean Patient With Brain Manganese Deposition Resulting From a Compound Heterozygous Mutation in the SLC39A14 Gene [PDF]
Journal of Movement Disorders, 2022 Mutations in the manganese transporter gene SLC39A14 lead to inherited disorders of manganese metabolism. Chelation therapy with edetate calcium disodium (SLC39A14 deficiencyTA) is known to effectively reduce manganese deposition.
Jae-Hyeok Lee, Jin-Hong Shin
doaj +1 more source
Annals of Indian Academy of Neurology, 2022 Background: Most centers in developing countries prefer chelation therapy with D-penicillamine for the management of Wilson's disease (WD) because of its easy availability and affordability. Neurological worsening following treatment with D-penicillamine
Madhan Kumar +5 more
doaj +1 more source